Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-03-05 @ 12:07 AM
Study NCT ID:
NCT04593927
Status:
COMPLETED
Last Update Posted:
2024-02-12
First Post:
2020-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Secondary Progressive Multiple Sclerosis (SPMS) | View |